Literature DB >> 20819118

PHLPP1 splice variants differentially regulate AKT and PKCα signaling in hippocampal neurons: characterization of PHLPP proteins in the adult hippocampus.

Travis C Jackson1, Jonathan D Verrier, Susan Semple-Rowland, Ashok Kumar, Thomas C Foster.   

Abstract

Pleckstrin homology and leucine rich repeat protein phosphatases (PHLPPs) are a novel class of potent protein kinase B (AKT) inhibitors that have been intensely investigated in relation to AKT activity in cancer. Currently, our understanding of the role of PHLPP1α in the central nervous system is limited. In this study, we characterized PHLPP protein expression and target kinases in the adult hippocampus. We directly verify PHLPP1α inhibits AKT in hippocampal neurons and demonstrate a novel role for PHLPP1β/SCOP, to promote AKT activation. PHLPP1α expression changes dramatically in the hippocampus during development, constituting the most abundant PHLPP protein in adult neurons. Further, while all PHLPP proteins could be observed in the cytosolic fraction, only PHLPP1α could be localized to the nucleus. The results provide unique evidence for a divergence in the function of PHLPP1α and PHLPP1β/SCOP, and suggest that PHLPP1α plays a major role in regulating AKT signaling in neurons.
© 2010 The Authors. Journal of Neurochemistry © 2010 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819118      PMCID: PMC3730267          DOI: 10.1111/j.1471-4159.2010.06984.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  35 in total

1.  Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms.

Authors:  Isao Hirano; Satoki Nakamura; Daisuke Yokota; Takaaki Ono; Kazuyuki Shigeno; Shinya Fujisawa; Kaori Shinjo; Kazunori Ohnishi
Journal:  J Biol Chem       Date:  2009-03-04       Impact factor: 5.157

2.  Protein phosphatase PHLPP1 controls the light-induced resetting of the circadian clock.

Authors:  Satoru Masubuchi; Tianyan Gao; Audrey O'Neill; Kristin Eckel-Mahan; Alexandra C Newton; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

3.  SCOP, a novel gene product expressed in a circadian manner in rat suprachiasmatic nucleus.

Authors:  K Shimizu; M Okada; A Takano; K Nagai
Journal:  FEBS Lett       Date:  1999-09-24       Impact factor: 4.124

Review 4.  SCOP/PHLPP and its functional role in the brain.

Authors:  Kimiko Shimizu; Scott M Mackenzie; Daniel R Storm
Journal:  Mol Biosyst       Date:  2009-09-30

5.  Activation of Akt signaling in rat brain by intracerebroventricular injection of ouabain: a rat model for mania.

Authors:  Hyun-Sook Yu; Se Hyun Kim; Hong Geun Park; Yong Sik Kim; Yong Min Ahn
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-04-18       Impact factor: 5.067

6.  Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis.

Authors:  Meng Qiao; Yaqi Wang; Xiaoen Xu; Jing Lu; Yongli Dong; Wufan Tao; Janet Stein; Gary S Stein; James D Iglehart; Qian Shi; Arthur B Pardee
Journal:  Mol Cell       Date:  2010-05-28       Impact factor: 17.970

7.  Serine/threonine kinase akt activation regulates the activity of retinal serine/threonine phosphatases, PHLPP and PHLPPL.

Authors:  Yogita Kanan; Hiroyuki Matsumoto; Hongman Song; Maxim Sokolov; Robert E Anderson; Raju V S Rajala
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

8.  FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.

Authors:  Huadong Pei; Liang Li; Brooke L Fridley; Gregory D Jenkins; Krishna R Kalari; Wilma Lingle; Gloria Petersen; Zhenkun Lou; Liewei Wang
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

9.  Akt signal transduction dysfunction in Parkinson's disease.

Authors:  Suzanne Timmons; Meghan F Coakley; Aileen M Moloney; Cora O' Neill
Journal:  Neurosci Lett       Date:  2009-10-01       Impact factor: 3.046

10.  PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum.

Authors:  A Saavedra; J M García-Martínez; X Xifró; A Giralt; J F Torres-Peraza; J M Canals; M Díaz-Hernández; J J Lucas; J Alberch; E Pérez-Navarro
Journal:  Cell Death Differ       Date:  2009-09-11       Impact factor: 15.828

View more
  20 in total

1.  Suppression of survival signalling pathways by the phosphatase PHLPP.

Authors:  Audrey K O'Neill; Matthew J Niederst; Alexandra C Newton
Journal:  FEBS J       Date:  2012-03-16       Impact factor: 5.542

Review 2.  Dissecting the age-related decline on spatial learning and memory tasks in rodent models: N-methyl-D-aspartate receptors and voltage-dependent Ca2+ channels in senescent synaptic plasticity.

Authors:  Thomas C Foster
Journal:  Prog Neurobiol       Date:  2012-01-28       Impact factor: 11.685

Review 3.  Calpain-1 and Calpain-2: The Yin and Yang of Synaptic Plasticity and Neurodegeneration.

Authors:  Michel Baudry; Xiaoning Bi
Journal:  Trends Neurosci       Date:  2016-02-10       Impact factor: 13.837

4.  Oxidative stress induces release of 2'-AMP from microglia.

Authors:  Travis C Jackson; Shawn E Kotermanski; Patrick M Kochanek; Edwin K Jackson
Journal:  Brain Res       Date:  2018-11-03       Impact factor: 3.252

5.  Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.

Authors:  Travis C Jackson; Jonathan D Verrier; Tomas Drabek; Keri Janesko-Feldman; Delbert G Gillespie; Thomas Uray; Cameron Dezfulian; Robert S Clark; Hülya Bayir; Edwin K Jackson; Patrick M Kochanek
Journal:  J Pharmacol Exp Ther       Date:  2013-09-10       Impact factor: 4.030

6.  Adenosine production by brain cells.

Authors:  Edwin K Jackson; Shawn E Kotermanski; Elizabeth V Menshikova; Raghvendra K Dubey; Travis C Jackson; Patrick M Kochanek
Journal:  J Neurochem       Date:  2017-04-06       Impact factor: 5.372

7.  Role of CNPase in the oligodendrocytic extracellular 2',3'-cAMP-adenosine pathway.

Authors:  Jonathan D Verrier; Travis C Jackson; Delbert G Gillespie; Keri Janesko-Feldman; Rashmi Bansal; Sandra Goebbels; Klaus-Armin Nave; Patrick M Kochanek; Edwin K Jackson
Journal:  Glia       Date:  2013-08-06       Impact factor: 7.452

8.  Physiological activation of Akt by PHLPP1 deletion protects against pathological hypertrophy.

Authors:  Courtney Moc; Amy E Taylor; Gino P Chesini; Cristina M Zambrano; Melissa S Barlow; Xiaoxue Zhang; Åsa B Gustafsson; Nicole H Purcell
Journal:  Cardiovasc Res       Date:  2014-11-19       Impact factor: 10.787

9.  Distinct roles for μ-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration.

Authors:  Yubin Wang; Victor Briz; Athar Chishti; Xiaoning Bi; Michel Baudry
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

10.  PHLPP1 gene deletion protects the brain from ischemic injury.

Authors:  Bo Chen; Jessica A Van Winkle; Patrick D Lyden; Joan H Brown; Nicole H Purcell
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.